We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601216:SSEInner Mongolia Junzheng Energy & Chemical Group Co., Ltd. Class A Analysis

Data as of 2026-05-28 - not real-time

CN¥5.13

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 5.13 CNY, which sits below its 20‑day (5.48) and 50‑day (5.50) simple moving averages and also under the 200‑day average (5.40), signaling a bearish technical stance. The RSI of 34.2 hints at modest oversold pressure, while the MACD histogram remains negative (-0.034), reinforcing the downtrend. Current price hovers just above the identified support level of 5.08 and well under the resistance at 5.75, leaving limited upside in the near term. Volume is on a decreasing trend despite still high absolute levels, and 30‑day volatility is elevated at 25%, though the computed beta is exceptionally low (0.09), suggesting limited market‑wide sensitivity.
Fundamentally, revenue has slipped by 1.9% year‑over‑year, yet margins remain respectable (gross 19.6%, operating 13.9%, profit 12.1%) and cash generation is strong with operating cash flow of 5.35 bn CNY. The balance sheet shows near‑par debt and cash levels (6.22 bn each) and a modest debt‑to‑equity of 20.2. Dividend yield stands at 2.9% with a payout ratio under 42%, supporting sustainability. The DCF‑derived fair value of 5.07 CNY aligns closely with the market price, indicating the stock is roughly fairly valued and leans toward a value‑oriented profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • price below short‑term moving averages
  • negative MACD and modest oversold RSI
  • support level proximity with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • fair valuation near DCF fair value
  • stable cash flow and sustainable dividend
  • moderate sector and regulatory exposure

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • value‑oriented fundamentals with solid margins
  • low beta and strong balance sheet
  • attractive dividend yield and payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth-1.90%
Profit Margin12.05%
P/E Ratio14.3
ROE10.25%
ROA4.50%
Debt/Equity20.15
P/B Ratio1.4
Op. Cash FlowCN¥5.3B
Free Cash FlowCN¥3.2B

Technical Analysis

TrendNeutral
RSI34.2
SupportCN¥5.08
ResistanceCN¥5.75
MA 20CN¥5.48
MA 50CN¥5.50
MA 200CN¥5.40
MACDBearish
VolumeDecreasing
Fear & Greed Index93.32

Valuation

Fair ValueCN¥5.07
GradeFair
TypeValue
Dividend Yield2.92%

Risk Assessment

Beta0.09
Volatility25.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.